https://www.marketscreener.com/quote/stock/ENTASIS-THERAPEUTICS-HOLD-46353304/news/Entasis-Therapeutics-Presents-Data-on-Sulbactam-Durlobactam-and-ETX0462-at-2022-ASM-Microbe-Annual-40681170/?utm_source=telegram&utm_medium=social&utm_campaign=share